Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

PRX-OTC from PhaseRx receives FDA orphan drug designation

Nov. 24, 2016

Novo Nordisk's Xultophy wins FDA approval for type 2 diabetes

Nov. 22, 2016

FDA approves Soliqua for type 2 diabetes

Nov. 22, 2016

Intarcia Therapeutics submits NDA for ITCA-650

Nov. 22, 2016

Agilis Biotherapeutics' AGIL-AADC wins FDA rare pediatric disease designation

Nov. 18, 2016

FDA approves Intrarosa to treat dyspareunia in postmenopausal women

Nov. 18, 2016

Agilis Biotherapeutics treats first patient in phase IIb study of AGIL-AADC

Nov. 17, 2016

Tianjin Institute of Pharmaceutical Research patents URAT1 inhibitors

Nov. 17, 2016

FDA grants orphan drug designation to Genexine's GX-H9

Nov. 17, 2016

Arena Pharmaceuticals patents 5-HT2C receptor agonists

Nov. 16, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026